Report Detail
Global Hereditary Angioedema Drug Market Insights and Forecast to 2026
- RnM4153694 |
- 24 August, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Hereditary Angioedema Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hereditary Angioedema Drug market is segmented into
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Segment by Application, the Hereditary Angioedema Drug market is segmented into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Hereditary Angioedema Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hereditary Angioedema Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hereditary Angioedema Drug Market Share Analysis
Hereditary Angioedema Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereditary Angioedema Drug business, the date to enter into the Hereditary Angioedema Drug market, Hereditary Angioedema Drug product introduction, recent developments, etc.
The major vendors covered:
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
...
1 Study Coverage
- 1.1 Hereditary Angioedema Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Hereditary Angioedema Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Hereditary Angioedema Drug Market Size Growth Rate by Type
- 1.4.2 C1 Esterase Inhibitor
- 1.4.3 Kallikrein Inhibitor
- 1.4.4 Selective Bradykinin B2 Receptor Antagonist
- 1.5 Market by Application
- 1.5.1 Global Hereditary Angioedema Drug Market Size Growth Rate by Application
- 1.5.2 Retail Pharmacies
- 1.5.3 Hospital Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Hereditary Angioedema Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Hereditary Angioedema Drug Revenue 2015-2026
- 2.1.2 Global Hereditary Angioedema Drug Sales 2015-2026
- 2.2 Global Hereditary Angioedema Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Hereditary Angioedema Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Hereditary Angioedema Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hereditary Angioedema Drug Competitor Landscape by Players
- 3.1 Hereditary Angioedema Drug Sales by Manufacturers
- 3.1.1 Hereditary Angioedema Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Hereditary Angioedema Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Hereditary Angioedema Drug Revenue by Manufacturers
- 3.2.1 Hereditary Angioedema Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Hereditary Angioedema Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Hereditary Angioedema Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Hereditary Angioedema Drug Revenue in 2019
- 3.2.5 Global Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Hereditary Angioedema Drug Price by Manufacturers
- 3.4 Hereditary Angioedema Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Hereditary Angioedema Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Hereditary Angioedema Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Hereditary Angioedema Drug Market Size by Type (2015-2020)
- 4.1.1 Global Hereditary Angioedema Drug Sales by Type (2015-2020)
- 4.1.2 Global Hereditary Angioedema Drug Revenue by Type (2015-2020)
- 4.1.3 Hereditary Angioedema Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Hereditary Angioedema Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Hereditary Angioedema Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Hereditary Angioedema Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Hereditary Angioedema Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Hereditary Angioedema Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Hereditary Angioedema Drug Market Size by Application (2015-2020)
- 5.1.1 Global Hereditary Angioedema Drug Sales by Application (2015-2020)
- 5.1.2 Global Hereditary Angioedema Drug Revenue by Application (2015-2020)
- 5.1.3 Hereditary Angioedema Drug Price by Application (2015-2020)
- 5.2 Hereditary Angioedema Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Hereditary Angioedema Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Hereditary Angioedema Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Hereditary Angioedema Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Hereditary Angioedema Drug by Country
- 6.1.1 North America Hereditary Angioedema Drug Sales by Country
- 6.1.2 North America Hereditary Angioedema Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Hereditary Angioedema Drug Market Facts & Figures by Type
- 6.3 North America Hereditary Angioedema Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe Hereditary Angioedema Drug by Country
- 7.1.1 Europe Hereditary Angioedema Drug Sales by Country
- 7.1.2 Europe Hereditary Angioedema Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Hereditary Angioedema Drug Market Facts & Figures by Type
- 7.3 Europe Hereditary Angioedema Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Hereditary Angioedema Drug by Region
- 8.1.1 Asia Pacific Hereditary Angioedema Drug Sales by Region
- 8.1.2 Asia Pacific Hereditary Angioedema Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Hereditary Angioedema Drug Market Facts & Figures by Type
- 8.3 Asia Pacific Hereditary Angioedema Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Hereditary Angioedema Drug by Country
- 9.1.1 Latin America Hereditary Angioedema Drug Sales by Country
- 9.1.2 Latin America Hereditary Angioedema Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Hereditary Angioedema Drug Market Facts & Figures by Type
- 9.3 Central & South America Hereditary Angioedema Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Hereditary Angioedema Drug by Country
- 10.1.1 Middle East and Africa Hereditary Angioedema Drug Sales by Country
- 10.1.2 Middle East and Africa Hereditary Angioedema Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Hereditary Angioedema Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa Hereditary Angioedema Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Pharming Group NV
- 11.1.1 Pharming Group NV Corporation Information
- 11.1.2 Pharming Group NV Description and Business Overview
- 11.1.3 Pharming Group NV Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pharming Group NV Hereditary Angioedema Drug Products Offered
- 11.1.5 Pharming Group NV Related Developments
- 11.2 Takeda
- 11.2.1 Takeda Corporation Information
- 11.2.2 Takeda Description and Business Overview
- 11.2.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Takeda Hereditary Angioedema Drug Products Offered
- 11.2.5 Takeda Related Developments
- 11.3 CSL Limited
- 11.3.1 CSL Limited Corporation Information
- 11.3.2 CSL Limited Description and Business Overview
- 11.3.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 CSL Limited Hereditary Angioedema Drug Products Offered
- 11.3.5 CSL Limited Related Developments
- 11.4 IBio Inc.
- 11.4.1 IBio Inc. Corporation Information
- 11.4.2 IBio Inc. Description and Business Overview
- 11.4.3 IBio Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 IBio Inc. Hereditary Angioedema Drug Products Offered
- 11.4.5 IBio Inc. Related Developments
- 11.5 BioCryst Pharmaceuticals, Inc.
- 11.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
- 11.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview
- 11.5.3 BioCryst Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered
- 11.5.5 BioCryst Pharmaceuticals, Inc. Related Developments
- 11.6 Ionis Pharmaceuticals, Inc.
- 11.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
- 11.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
- 11.6.3 Ionis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered
- 11.6.5 Ionis Pharmaceuticals, Inc. Related Developments
- 11.1 Pharming Group NV
- 11.1.1 Pharming Group NV Corporation Information
- 11.1.2 Pharming Group NV Description and Business Overview
- 11.1.3 Pharming Group NV Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pharming Group NV Hereditary Angioedema Drug Products Offered
- 11.1.5 Pharming Group NV Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Hereditary Angioedema Drug Market Estimates and Projections by Region
- 12.1.1 Global Hereditary Angioedema Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global Hereditary Angioedema Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America Hereditary Angioedema Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: Hereditary Angioedema Drug Sales Forecast (2021-2026)
- 12.2.2 North America: Hereditary Angioedema Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: Hereditary Angioedema Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe Hereditary Angioedema Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: Hereditary Angioedema Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: Hereditary Angioedema Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: Hereditary Angioedema Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Hereditary Angioedema Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Hereditary Angioedema Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Hereditary Angioedema Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Hereditary Angioedema Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Hereditary Angioedema Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Hereditary Angioedema Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: Hereditary Angioedema Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Hereditary Angioedema Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Hereditary Angioedema Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Hereditary Angioedema Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Hereditary Angioedema Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Hereditary Angioedema Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Hereditary Angioedema Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Hereditary Angioedema Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Hereditary Angioedema Drug. Industry analysis & Market Report on Hereditary Angioedema Drug is a syndicated market report, published as Global Hereditary Angioedema Drug Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Hereditary Angioedema Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
